glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Frontiers Expert Opinion: Optimum Clinical Approach

Your clinician will determine the route, dose, and titration schedule based on your goals, prior GLP1 exposure, sideeffect tolerance, and medical history

Among the drugs in the pipeline are ampakines, which target a type of glutamate receptor in the brain

Participants were shown lists of words and, to encode them, were asked to identify whether the words were in capital or lowercase letters, which requires shallow or perceptual processing, or whether they represented objects that occurred in nature or were artificially made, which requires deep or semantic processing

doi: 10.1111/nmo.12804 196 NasriKJamilianMRahmaniEBahmaniFTajabadi-EbrahimiMAsemiZ